Today’s first Virtual   #RegeneronISEF session is on fighting   #COVID19 with   #science, moderated by  @ScienceNews’s  @NancyShute & featuring  @Regeneron scientists Christos Kyratsous, Leah Lipsich, & Serge Monpoeho.  https://bit.ly/3bhTWM3 ">https://bit.ly/3bhTWM3&q...
                        
                        
                        
                        
                                                
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Christos Kyratsous is the Vice President of Research, Infectious Diseases and Viral Vector Technologies.   #RegeneronISEF
                        
                        
                        
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Leah Lipsich is the Vice President of Strategic Program Direction, Global Development.   #RegeneronISEF
                        
                        
                        
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Serge Monpoeho is the Senior Director, Quality Control and Chief Virologist.   #RegeneronISEF
                        
                        
                        
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Thrilled to have these  @Regeneron scientists with us today & hear about the exciting work they& #39;re doing to combat   #COVID19!
                        
                        
                        
                        
                                                
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Q: When did you first realize that this particular virus was going to become a global threat?   #RegeneronISEF
                        
                        
                        
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Leah Lipsich: In January we started seeing reports about the coronavirus. We started getting concerned & marshaled our resources in research & development to be prepare, hoping for the best but expecting the worst.   #RegeneronISEF
                        
                        
                        
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Q: One of things you& #39;re looking closely at is a treatment that  @Regeneron developed for Ebola virus. How might that have the possibility for treating a completely different virus?   #RegeneronISEF
                        
                        
                        
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Christos Kyratsous: Although the viruses are different from one another, we& #39;re using the same technologies that we& #39;ve applied before, which gives us confidence that we can do it again.   #RegeneronISEF
                        
                        
                        
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Q: Antibodies are something we have in our body that fights viruses. But you& #39;re making a customized antibody. How& #39;s that different from the antibodies that we have in ourselves?   #RegeneronISEF
                        
                        
                        
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Christos Kyratsous: When humans are infected, their immune systems react by making antibodies. We’re mimicking the exact same process in humanized mice & selecting the most potent antibodies out of those.   #RegeneronISEF
                        
                        
                        
                        
                                                
                    
                    
                                    
                    
                        
                        
                        Leah Lipsich on drug trials that fail: It& #39;s very important that you learn even in a study that gives disappointing results. You learn what to do with that data & move it on to the next step. Even a disappointing result tells you a lot.   #RegeneronISEF
                        
                        
                        
                        
                                                
                        
                                                
                    
                    
                
                 
                         Read on Twitter
Read on Twitter 
                             
                             
                             
                                     
                                    